S Wenzel, M Castro, J Corren, J Maspero, L Wang… - The Lancet, 2016 - thelancet.com
Background Dupilumab, a fully human anti-interleukin-4 receptor α monoclonal antibody,
inhibits interleukin-4 and interleukin-13 signalling, key drivers of type-2-mediated …